Skip to content
Neurovalens logo — We develop non-invasive neurostimulation products used to
so...

Neurovalens

We develop non-invasive neurostimulation products used to solve some of the world’s greatest health challenges

Founded 2013 United Kingdom United Kingdom 30 employees Venture round Total: $15.76M Biotechnology, Health Care +1

General Information

Company Name Neurovalens
Founded Year 2013
Location United Kingdom United Kingdom
Employees 30
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Neurovalens. To contact Neurovalens, visit neurovalens.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neurovalens compare?

A PDF of Neurovalens and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neurovalens soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Neurovalens

Neurovalens is a UK-based health-tech startup that has been making waves in the biotechnology and healthcare industries since its establishment in 2013. Its flagship product, Modius, utilizes non-invasive neurostimulation to aid weight loss, addressing a significant health challenge. The company has garnered substantial recognition, winning prestigious accolades such as the 2018 CES Innovation Award and the 2019 Future Planet Awards in the Health Category. Their success has also been noted by investors, with the latest funding round of £2.10M from UK Investors in an undisclosed Series Unknown investment on 08 April 2024. Neurovalens has not only made its mark through innovation but also by gaining industry acclaim, securing the titles of Start-Up of the Year at the 2018 Digital DNA Awards and Innovative Business of the Year at the 2018 BEFTA Awards. The startup's impressive growth and accolades position it as an attractive investment opportunity in the ever-evolving healthcare technology landscape, with its potential to address pressing global health concerns.

Business keywords: neurostimulation, health tech, non-invasive products, weight management, neuro-technology, innovation, start-up, award-winning, CES Innovation Award, technology, disruptive tech, investment, entrepreneurship

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £2.10M 9
Techstart Ventures, Angel CoFund +7
08 Apr 2024
Non Equity Assistance Undisclosed 1
MedTech Innovator
07 Jun 2022
Grant £225.00K 1
Invest Northern Ireland
02 Dec 2021
Series A £5.10M 6
Techstart Ventures, Angel CoFund +4
20 Jul 2020
Venture Round $750.00K -
15 Oct 2019
Series A £4.60M 6
Techstart Ventures, Angel CoFund +4
14 Mar 2019
Equity Crowdfunding $1.60M -
17 Oct 2017
Seed Round £1.10M 3
Techstart Ventures, Angel CoFund +1
19 Jul 2017
Seed Round £285.00K 1
Techstart Ventures
04 Dec 2015

Neurovalens Alternatives & Competitors

View All Alternatives
Neurovalens vs

Swemax - Your body's voice

1 employees
Biotechnology, Health Care
Neurovalens vs

Handing millions the power to achieve a healthy weight

Venture round
27 employees
Health Care, Life Sciences
Neurovalens vs

America’s premier weight-loss and metabolic health-solutions company.

Post-IPO Equity
38 employees
Biotechnology, Health Care

FAQ About Neurovalens

We develop non-invasive neurostimulation products used to solve some of the world’s greatest health challenges
Neurovalens was founded in 2013.
Neurovalens is headquartered in United Kingdom.
Neurovalens operates in Biotechnology, Health Care and Life Sciences. Its work centres on neurostimulation, health tech, non-invasive products and weight management.
Neurovalens has approximately 30 employees.
Neurovalens has completed 9 funding rounds, raising a total of $15.76M. The latest funding stage is Venture round.
Top alternatives and competitors to Neurovalens include Biometrica Sensors, Oxford Medical Products, ReShape Lifesciences Inc., Aramune Technologies Limited, NURO CORP.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurovalens and Biometrica Sensors are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neurovalens, https://bouncewatch.com/company/neurovalens, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout